Pharmaceutical Industry Information Portal

HomeTagsAnti-coronavirus drug

All posts by tag

Anti-coronavirus drug

The drug of Uzbek scientists included in the protocol for COVID treatment

The “Rutan, 100 mg” drug, developed by scientists of the Institute of Bioorganic Chemistry of the Academy of Sciences of the Republic of Uzbekistan,...

Gamaleya Center starts testing its anti-COVID medicine based on monoclonal antibodies

Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is launching trials of its new anti-COVID medicine based on monoclonal antibodies, the center’s chief...

Ascletis Pharma expands Ritonavir oral tablet production in China

Ascletis Pharma Inc. announced the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2...

Blood plasma-based drug against COVID-19 successfully passes clinical trials

The COVID-globulin medicine against coronavirus based on convalescent blood plasma has successfully passed clinical trials and received a permanent certification by the Russian Health...

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...

FDA Authorizes Use of Oral Antiviral Molnupiravir for Mild to Moderate COVID-19

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the U.S. Food and Drug Administration (FDA) has...
spot_img

Expert Articles

spot_img